PRE-MARKET MOVERS

 

UPGRADES

2. GILD:$GILD upgraded to Outperform at BMO Capital

 

DOWNGRADES

6. ILMN:$ILMN downgraded to Underweight at First Analysis
8. PFE:$PFE downgraded to Hold at Argus, downgraded to Market Perform at BMO Capital

 

EARNINGS

 

Trending Social Alerts

1. ANTM:$ANTM CEO Swedish on #Obamacare reforms: extend Cadillac Tax freeze, extend risk adjustment, flexibility on products, tighten grace period.
3. AGN:$AGN Announces $10 Billion Accelerated Share Repurchase, Initiation of Cash Dividend in 2017
4. BRCD:Broadcom to acquire Brocade Communications in $5.9B deal • $BRCD $AVGO
9. TWX:Time Warner Reports Q3 Adj. EPS $1.83 vs $1.37 Est., Sales $7.2B vs $7B Est. $TWX
11. BABA:$BABA Alibaba Q3 16 Earnings Results: -Adj EPS: $0.79 -Revenue: $5.1B

 

Trending News Headlines

1. Gilead was great once but is now awful and depressing

I want the old Gilead back! The present Gilead, with a stock down 27% for the year, trading at levels not seen since April 2014, is too sad to bear.

2. Andy Biotech on Twitter

“$CEMP — Long list of safety/pharmacokinetic/efficacy issues that FDA identified”

3. Andy Biotech on Twitter

“$CEMP — FDA: “We conclude that these findings comprise a genuine liver injury signal. “”

4. Briefing Information for the November 4, 2016 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

5. 2016 Meeting Materials, Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee)

Page Last Updated: 11/02/2016 Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players . Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English

6. Palatin female libido-boosting shot fails crucial sex frequency test

Palatin appears be to playing a game of bait and switch with the design of its phase III studies.

7. Alibaba Jumps On Q3 Earnings Beat; Cloud Loss Narrowed

Alibaba Group (BABA) jumped 3.6% in pre-market after reporting better-than-expected third-quarter earnings. Revenue at Alibaba grew 55% from a year ago to 34.29 billion yuan, broadly in line with the 54% growth predicted by the street. But earnings per share came in at 5.26 yuan ($0.79), well above street estimate of 4.69 yuan, or $0.69. […]

8. Andy Biotech on Twitter

“$CEMP — As expected, liver tox is the key focus of solithromycin safety issues”

9. U.S. Steel Cuts Annual View, Posts Third-Quarter Profit

U.S. Steel Corp. lowered its full-year guidance as it continues to recover from unplanned outages in the third quarter and invest in additional maintenance spending. The company posted a third-quarter profit.

10. Gilead Quarterly Profit Misses on Low Hepatitis C Drug Sales

Gilead Sciences Inc. posted third-quarter profit that missed analysts’ estimates amid steadily declining sales of its hepatitis C drugs, though it isn’t rushing to fill its pipeline with deals.

11. zach on Twitter

“yikes $CEMP”

12. Yelp shares jump after company reports surprise profit

By

13. Private companies created fewer jobs than expected in October as pace of growth slows

ADP also revised job creation numbers for other months as part of a new measuring model.

14. Chipmaker Broadcom to buy network gear maker Brocade for $5.5 billion

Chipmaker Broadcom Ltd (AVGO.O) said on Wednesday it would buy network gear maker Brocade Communications Systems Inc (BRCD.O) for $5.5 billion in cash, to expand its fiber channel and data storage businesses.

15. Allergan expands buyback to $15 billion, sets first quarterly dividend

Allergan Plc (AGN.N) on Wednesday expanded its share buyback program by $5 billion to $15 billion and set its first-ever quarterly dividend, cushioning the impact of lower-than-expected quarterly revenue and lifting its shares.

Technology News

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

Share This

Share this post with your friends!